BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2465940)

  • 21. [Methotrexate in gynecologic oncology].
    Isonishi S; Terashima Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
    Willemse PH; Aalders JG; Bouma J; Sleijfer DT
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of management of gestational trophoblastic tumor in National Taiwan University Hospital.
    Ouyang PC
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1544-52. PubMed ID: 2543310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
    Theodore C; Azab M; Droz JP; Assouline A; George M; Piot G; Bellet D; Michel G; Amiel JL
    Cancer; 1989 Nov; 64(9):1824-8. PubMed ID: 2551474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Oct; 19(2):173-81. PubMed ID: 6208089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms.
    Goldstein DP; Berkowitz RS
    Semin Oncol; 1982 Jun; 9(2):191-7. PubMed ID: 6289462
    [No Abstract]   [Full Text] [Related]  

  • 30. Poor-prognosis gestational trophoblastic disease: an update.
    Surwit EA; Alberts DS; Christian CD; Graham VE
    Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD).
    Sablińska B; Kietlińska Z; Zieliński J
    Eur J Gynaecol Oncol; 1993; 14 Suppl():146-51. PubMed ID: 8200366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update in cancer chemotherapy: genitourinary tract cancer, Part 7: Gestational trophoblastic neoplasms.
    Wright JC
    J Natl Med Assoc; 1988 Jul; 80(7):753-61. PubMed ID: 2841462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestational trophoblastic disease presenting as a large metastasis to the finger.
    Hetzel DJ; Olt GJ; Sorosky JI; Mortel R; Singapuri K; Podczaski ES
    Gynecol Oncol; 1996 Oct; 63(1):123-6. PubMed ID: 8898181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic gestational trophoblastic disease: secondary chemotherapy.
    Lurain JR; Piver MS
    N Y State J Med; 1980 Feb; 80(2):234-7. PubMed ID: 6246471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.